Key result
Antihypertensive treatment with enalapril or hydralazine/hydrochlorothiazide improved EDHF-mediated maximal relaxation in the mesenteric artery of hypertensive rats.
Why the study?
Does antihypertensive treatment improve EDHF-mediated hyperpolarization and relaxation in the mesenteric artery of spontaneously hypertensive rats?
Does antihypertensive treatment improve EDHF-mediated hyperpolarization and relaxation in the mesenteric artery of spontaneously hypertensive rats?
Antihypertensive treatment improves EDHF-mediated endothelial function in the mesenteric arteries of spontaneously hypertensive rats, independent of the specific drug class used.
Answers are grounded in this paper and cite their sources.
Antihypertensive restoration of EDHF hyperpolarization in SHR models merits human studies; leaves open direct clinical translation.
BACKGROUND: The vascular endothelium releases endothelium-derived hyperpolarizing factor (EDHF). The mesenteric arteries of 6- to 8-month-old spontaneously hypertensive rats (SHRs) exhibit an impairment of the hyperpolarization induced by acetylcholine via EDHF. METHODS AND RESULTS: We determined whether antihypertensive treatment can improve EDHF-mediated responses in SHRs. Beginning at age 8 to 9 months, the animals were treated with either enalapril (40 mg x kg(-1) x d(-1)) (SHR-Es) or a combination of hydralazine (25 mg x kg(-1) x d(-1)) and hydrochlorothiazide (7.5 mg x kg(-1) x d(-1)) (SHR-Hs) for 3 months. The control groups were age-matched SHRs (SHR-Cs) and Wistar Kyoto rats (WKYs). The two treatments lowered the blood pressure to comparable extents. The acetylcholine-induced hyperpolarization in the mesenteric artery of treated SHRs improved to a level comparable to that in WKYs (acetylcholine 10(-5) mol/L with norepinephrine 10(-5) mol/L: SHR-E, -14.4 +/- 1.8; SHR-H, -12.0 +/- 1.3; SHR-C, -7.2 +/- 1.2; and WKY, -13.3 +/- 2.3 mV). EDHF-mediated relaxation, as assessed by relaxation to acetylcholine resistant to N(G)-nitro-L-arginine in norepinephrine-contracted rings, was markedly improved in treated SHRs (maximal relaxation: SHR-E, 79.3+/-3.2%; SHR-H, 47.4+/-8.6%; SHR-C, 4.8+/-2.4%; and WKY, 45.1+/-6.0%). When the rings were contracted with 77 mmol/L KCl to eliminate EDHF response, no difference was found in relaxation to acetylcholine among the four groups. Similarly, the hyperpolarization and relaxation to levcromakalim, a K+ channel opener, were comparable among the groups. CONCLUSIONS: Antihypertensive treatment improved EDHF-mediated hyperpolarization and relaxation in the mesenteric artery in SHRs, whereas NO-mediated relaxation did not appear to be modulated by drug therapy. Thus, alterations in the EDHF system may play a pivotal role in endothelial dysfunction and its improvement with drug therapy in SHRs.
No takes yet. Share an insight, caveat, or question.
Onaka et al. (1998) studied Hypertension (Spontaneously hypertensive rats). Enalapril or Hydralazine + Hydrochlorothiazide vs. Untreated spontaneously hypertensive rats and Wistar Kyoto rats was evaluated on Acetylcholine-induced hyperpolarization and EDHF-mediated relaxation in the mesenteric artery. Antihypertensive treatment with enalapril or hydralazine/hydrochlorothiazide improved EDHF-mediated maximal relaxation in the mesenteric artery of hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: